K-134

DB12685InvestigationalSmall molecule

K-134 has been used in trials studying the treatment of Intermittent Claudication.

Chemical structure of K-134
Mechanism
Curator reviewed
Formula / weight
C22H29N3O4 · 399.491 g/mol (avg)
Code names
OPC-33509

Resolves to

Compound
UNIIJ9J6NK6W4UCAS189362-06-9ChEMBLCHEMBL284838PubChem9908900
Structure
InChIKeyULGNGSQNNMKROG-WOJBJXKFSA-NSMILESO[C@@H]1CCCC[C@H]1N(C1CC1)C(=O)NCCCOC1=CC=C2NC(=O)C=CC2=C1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of K-134, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In